Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5443_Библиотеки_им_академика_М_И_Перельмана
.pdf
namic picture of molecular systems over time [61]. Fundamentally, MD simulations
allow the temporal evolution of a molecular system by solving Newton’s equations of
motion for a group of interacting atoms. MD simulations work on the basis of calculat-
ing forces between atoms, integrating equations of motion, and creating trajectories
that show atom movement.
12.4.1.2 Applications in studying nanocarrier interactions
When it comes to clarifying the molecular behavior of nanocarriers, MD simulations
are especially effective. Scientists utilize MD, structural alterations, and intermolecu-
lar interactions [62] in nanocarriers using MD simulations. For example, MD simula-
tions in the study of liposomes can reveal how the lipid bilayer changes in response
to medicines contained, impacting release kinetics and stability. MD simulations also
offer information on the variables governing regulated drug delivery by elu cidating
the mechanics of drug loading and release in polymeric nanoparticles [63].
12.4.1.3 Showcasing relevant studies
The ability of MD simulations to forecast the behavior of nanocarriers has been dem-
onstrated in recent research. MD simulations were used in a study to forecast drug
release profiles and encapsulation efficiency while investigating the relationship be-
tween paclitaxel and polymeric nanoparticles. The kinetics of drug-polymer interac-
tions were faithfully portrayed in the simulations, in agreement with experimental
findings. This demonstrates how well MD simulations can anticipate the complex
dance of molecules inside nanocarriers [64].
12.4.1.4 Monte Carlo simulation: predicting thermodynamics and kinetics
One of the most effective computational methods for forecasting the kinetic and ther-
modynamic parameters of molecular systems is MC simulation. This section delves
deeply into the comprehension of MC simulation, its applications, highlights pertinent
research, and examines the obstacles and potential avenues for growth in this ever-
evolving discipline [65].
12.4.1.5 Monte Carlo simulation in depth
The thermodynamic and kinetic properties of molecular systems are modeled using
probabilistic techniques called MC simulation. MC simulations concentrate on statisti-
12 Application of simulation system for selection of nanocarrier 283
https://t.me/med1917
cal sampling, in contrast to MD simulations that change systems over time. Because of
its intrinsic randomness, the method gets its name from the Monte Carlo Casino.
In practice, random configurations are sampled from a statistical ensemble dur-
ing MC simulations. These arrangements aid in the computation of observables and
shed light on thermodynamic quantities like entropy, free energy, and enthalpy [66].
Phase transitions, binding affinities, and reaction kinetics are three areas where the
approach excels.
12.4.1.6 Practical considerations in application
The correct description of the potential energy landscape and the selection of suitable
sampling techniques are key components of a successful MC simulation. To get accu-
rate results, researchers must carefully plan the simulation setup, use the right statis-
tical ensembles, and make sure there is enough sampling. To ensure that forecasts are
accurate, practical issues include choosing appropriate force fields, integration techni-
ques, and convergence criteria [67].
12.4.1.7 Quantitative structure–activity relationship (QSAR) modeling: deciphering
biological activity
Drug discovery, environmental research, and many other fields rely heavily on the po-
tent computer tool known as QSAR modeling. It acts as a link between biology and chem-
istry, enabling scientists to understand the intricate relationship between a molecule’s
biological activity and chemical structure. The process of designing and developing drugs
has been completely transformed by this creative method, which offers insightful knowl-
edge about the molecular characteristics that affect a compound’s safety and efficacy.
Fundamentally, QSAR entails the creation of mathematical models that link chem-
ical compounds’ physical characteristics to their biological activity[68]. Through the
application of sophi sticated statistical met hods and computational algorithms, scien-
tists can forecast a novel compound’s biological behavior by analyzing its structural
properties. This predictive capability lowers experimental costs, speeds up the drug
discovery process, and makes it easier to identify possible lead molecules.
The computation of molecular descriptors, dataset preparation, model construc-
tion, validation, and interpretation are important phases in QSAR modeling. Molecu-
lar descriptors, which include electronegativity, lipophilicity, and molecular weight,
are numerical depictions of a compound’s structure. Building mathematical models
that connect chemical structure to biological activity is based on these characteristics.
The pharmaceutical sector is one of th e main uses of QSAR, as the discovery of
bioactive molecules is an essential stage in the development of new drugs. By helping
researchers choose which compounds to synthesize and test, QSAR models ultimately
284 Abhishek Singh et al.
https://t.me/med1917
Figure 12.2: A quantitative structure–activity relationship workflow.
12 Application of simulation system for selection of nanocarrier 285
https://t.me/med1917
speed up the process of discovering new medicinal medicines. Furthermore, by direct-
ing structural alterations to increase lead compounds’ efficacy and minimize any pos-
sible negative effects, QSAR aids in their optimization [69].
QSAR modeling helps anticipate the ecological and toxicological consequences of
chemicals in environmental science. Regulatory bodies can know whether chemicals
are safe and what effect they will have on the environment by knowing how a chem-
ical’s structure affects living things.
Notwithstanding its many benefits, QSAR modeling has drawbacks, including the
requirement for vast and diverse datasets, data quality, and model resilience. Further-
more, research on the interpretability of QSAR models is still underway because confi-
dence in the models’ predictions depends on our ability to comprehend the underlying
biological mechanisms [70].
In the field of computational chemistry and biology, QSAR modeling is a cornerstone
because it provides a methodical and effective way to decipher the complex link be-
tween chemical structure and biological activity. It is anticipated that QSAR techniques
will develop further as technology progresses, improving their accuracy and suitability
across a range of scientific fields. One example of how QSAR is being used to drive inno-
vation and support a more efficient and sustainable approach to scientific research is its
incorporation into the processes of environmental risk assessment and drug discovery.
12.4.1.8 General scheme of a QSAR study
Three categories of chemoinformatic techniques were employed in the construction of
QSAR models: first, the extraction of descriptors from molecular structure; second, the se-
lection of those that are relevant to the activity under study; and third, the use of the de-
scriptor values as independent variables to establish a mapping that associates them with
the activity in question [71]. Figure 12.2 depicts the QSAR workflow, which helps under-
stand how chemical structure influences biological activity. This systematic approach en-
ables researchers to predict the effectiveness of new compounds, facilitating drug design
and optimization.
12.4.1.9 Defining QSAR and its role
A computational method known as QSAR modeling links a molecule’sphysicochemical
characteristics to its biological activity. QSAR models are useful in the context of nano-
carriers to forecast the relationship between the structural characteristics of carriers
and their interactions with biological systems [72]. When it comes to designing and opti-
mizing nanocarriers for particular therapeutic payloads, QSAR modeling is quite helpful.
286 Abhishek Singh et al.
https://t.me/med1917
12.4.1.10 Case studies demonstrating successful predictions
The effectiveness of QSAR modeling in forecasting nanocarrier biological activity is
demonstrated by a number of case studies. QSAR models were successful in predicting
the impact of polymer properties on drug release rates and therapeutic efficacy in a
study employing polymeric micelles for drug delivery. Researchers were able to opti-
mize medication delivery by customizing the characteristics of micelles thanks to the
models [73]. In a similar vein, QSAR modeling demonstrated the predictive power of
the technique by directing the selection of lipid compositions for improved stability
and targeted distribution in liposomal formulations.
Chemical dynamics, MC, and QSAR modeling – the theoretical underpinnings of
simulation systems – offer scientists potent instruments for investigating and compre-
hending the complex chemical interactions driving nanocarrier behavior [74]. By de-
ciphering the enigmas surrounding drug delivery at the atomic and molecular levels,
these approaches also provide prognostic information that directs the logical design
and optimization of nanocarriers for biopharmaceutically difficult drugs.
Table 12.2: Quantitative structure–activity relationship (QSAR) modeling: deciphering biological activity.
Aspect Description
Definition A computational method that establishes mathematical relationships between the
chemical structure of molecules and their biological activities.
Purpose To predict and understand the biological activity of molecules, facilitating drug
discovery and environmental risk assessment.
Key steps Computation of molecular descriptors, compilation of datasets, creation, validation,
and interpretation of models [].
Molecular
descriptors
Numerical depictions of a compound’s structure, such as electronegativity,
lipophilicity, and molecular weight.
Applications Drug discovery: quickens the process of identifying bioactive substances.
Environmental science: forecasts the effects of chemicals on the environment and
human health.
Advantages Directs lead optimization and compound prioritization, speeding up the drug
discovery process.
Cuts down experimental expenses by using computerized biological activity
prediction.
Challenges Data quality issues: dependence on accurate and diverse datasets.
Model robustness: ensuring the reliability of predictions across different datasets.
Ongoing
research
Improving interpretability: enhancing the understanding of the biological
mechanisms underlying QSAR predictions.
12 Application of simulation system for selection of nanocarrier 287
https://t.me/med1917
12.5 Computational techniques
Computational techniques are crucial in drug delivery research, particularly for se-
lecting nanocarriers for complex drugs. They involve the use of computer simulations
and models for understanding the mann er in which nanocarriers interact with the
drugs on a molecular level. These techniques assist researchers in making smart selec-
tions regarding which nanocarrier is appropriate for delivering various medications
[77]. The primary aspects associated with these methodologies and their role in the
selection of nano-arriers are [78]:
MD simulation: MD simulation is a key computational tool utilized in nanocarrier
selection. They are concerned with simulating the movements as well as interactions
of the atoms and molecules throughout time. MD simulations can be used to explore
the atomic behavior of pharmaceuticals and nanocarriers with regard to drug deliv-
ery [79]. Assessing how medications bind with carriers, the way carrier release drugs,
and the way carriers interact with other biological components within physiological
environments are all part of this simulation. MD models provides insight into the ki-
netics and thermodynamics of these processes, assisting researchers in understanding
more about the stability and efficiency of nanocarriers [80].
MC simulations are a probabilistic computer tool for predicting various thermody-
namic and kinetic parameters of systems. MC simulations can be used in drug deliv-
ery research to investigate the thermodynamic behavior of drug–carrier interactions
like drug loading, encapsulating efficiency, as well as drug release rates. Researchers
can use these simulations to forecast the lik elihood distribution of various states or
conformations, which aids in the design and optimization of nanocarriers for certain
medications [81].
QSAR modeling: QSAR modeling is a computer approach that involves establishing
quantitative connections between the structural properties of molecules and their bi-
ological activities. While QSAR modeling is commonly used to predict the activity of
drugs, it also has the potent ial to choose nanocarriers. Researchers can create QSAR
models that anticipate how distinct nanocarriers interact with certain medications or
Table 12.2 (continued)
Aspect Description
Future trends Incorporating cutting-edge computer methods to produce predictions with more
accuracy.
QSAR techniques will continue to change as technology progresses [].
288 Abhishek Singh et al.
https://t.me/med1917
biological targets by using relevant chemical descriptors. This can help in the develop-
ment of carriers with excellent drug delivery characteristics [82].
Experimental data integration: Computational approaches are most effective when
combined with experimental data. This includes correlating simulation results along
with real-world experimental data. Experiment data relating to drug release profiles,
toxicity evaluations, or bioavailability measures can be used to validate simulation
predictions. The combination of computational and experimental methodologies
yields a more complete understanding of DDS, improves predictive accuracy, and op-
timizes nanocarrier selection [83].
The importance of using both simulation data and experimental data
– Validation and reliability: Experimental data validates computational simula-
tions, developing trust in the models and the nanocarriers chosen. The alignment
of simulations and experiments strengthens the scientific foundation.
– Holistic understanding: Combining experiments with simulations provides a com-
prehensive understanding of DDSs. Simulations investigate molecular interactions,
whereas experiments provide real-world insights, offering a well-rounded view.
– Improved predictive power: Integration improves simulations’ predictive ability.
Experiment results evaluate and optimize computer models, improvi ng simula-
tions’ ability to anticipate complex drug–carrier interactions [84].
– Data-driven decisions: Data-driven decision-making is guided by the synergy. Sim-
ulations reduce down options, directing studies towards the most promising
methods and lowering reliance on trial-and-error methods.
– Efficient optimization: The feedback loop optimizes the design of nanocarriers.
Simulations guide carrier alterations, which are then confirmed in studies, result-
ing in improved and effective DDSs.
The efficient integration of computational models and experimental data is critical in
DD research and nanocarrier selection. Several examples demonstrate how these ap-
proaches complement one another: models predict drug release kinetics, toxic ef-
fects, targeted delivery, stabili ty and bioavailability increases, while studies validate
these predictions. This integrated approach ensures the accuracy of computational
models, gives a thorough understanding of DDSs, and promotes data-driven decisions,
resulting in more efficient and optimized drug delivery approaches that meet regula-
tory and therapeutic standards [77].
HPC: HPC is essential for improving simulation processes along with handling large-
scale studies. Researchers can use HPC to run complex simulations that have excellent
resolution, precision, and speed. This allows for the investigation of a broad range of
parameters that are needed, the optimization of nanocarrier designs, includi ng the
efficient analysis o f large datasets. HPC is especially useful for analyzing intricate
drug-carrier interaction and a large-scale simulation, thus making it a must-have tool
during nanocarrier selection [85].
12 Application of simulation system for selection of nanocarrier 289
https://t.me/med1917
12.5.1 HPC’s role in the acceleration of simulation processes
Speed and efficiency: Because HPC machines are equipped with strong processors
and large amounts of memory, simulations can be completed much more quickly.
Complex calculations or simulations that typically would take too long on conven-
tional computers can be accomplished in a fraction of the time on HPC clusters.
High resolution and precision: HPC computers can handle simulations with great detail
and precision, allowing researchers to gain a better understanding of drug–carrier inter-
action. This is especially useful when researching complex chemical processes and the
behavior of nanocarriers in biological environments [86].
Parameter exploration: In order to optimize nanocarrier design, large-scale simula-
tions frequently include the exploration of a wide variety of parameters. The large
number of simulations required to analyze various situations may be handled quickly
by HPC systems, resulting in data-driven decisions concerning most promising nano-
carrier possibilities.
Scalability: As HPC resources are extremely scalable, researchers can tailor their proc-
essing capacity to the exact needs of their simulations. This scalability is critical when
dealing with drug–carrier systems of increasing complexity [87].
12.5.2 Significance for large-scale studies
Comprehensive investigations: HPC enables researchers to conduct exhaustive and
comprehensive studies. This implies being able to investigate a wide range of carrier
characteristics, drug interactions, and even environmental conditions in order to ac-
quire an in-depth knowledge of the system.
Optimized nanocarrie r design: Lar ge-sca le investigations enabled by HPC enable
nanocarrier design optimization. Based on simulation results, researchers may adjust
carrier attributes, resulting in more effective DDSs [88].
Cost-effective research: Although HPC systems might be expensive to install and oper-
ate, they ultimately provide cost-effective research. The time saved in computing op-
erations, as w ell as the ability to rapidly explore a large parameter space, can
significantly lower the overall expense of DD research.
Data-driven decision-making is facilitated by the ability to process huge amount of
data via large-scale simulations. Researchers can use empirical facts and statistical
studies to help them choose the best nanocarriers for specific drugs [89].
290 Abhishek Singh et al.
https://t.me/med1917
12.6 Case studies and applications
Case study Description References
Enhancing
bioavailability
A poorly soluble antitumor drug with inadequate bioavailability
was addressed. The simulations enhanced the drug solubility of
lipid-based nanocarriers substantially. Experiment validation
demonstrated increased bioavailability, which bodes well for more
successful cancer treatment.
[]
Targeted delivery Optimized nanocarriers for cardiovascular DD. Molecular dynamic
simulations assisted the selection of nanocarriers with excellent
surface characteristics for heart cell targeting. Experiments in vivo
revealed greater drug accumulation at the target region, resulting
in improved therapeutic efficacy with fewer side effects.
[]
Long-acting drug
delivery
Addressed a difficult peptide medication that required longer
release. Polymeric nanocarrier stability as well as drug-release
kinetics were modeled in simulations, resulting in the determination
of a highly stable and even long-acting nanocarrier. Experiment
results indicated constant long-term medication release.
[]
Overcoming drug
instability
The instability associated with a therapeutic protein susceptible to
denaturation or aggregation was addressed. The protein was
protected by a surface-modified liposomal nanocarrier discovered
using molecular dynamic simulations. Experiment results
confirmed improved stability.
[]
Reducing systemic
toxicity
The purpose of the study was to reduce an antiviral drug’s
systemic toxicity. The choice of the positive-charged polymeric
nanocarrier was influenced by Monte Carlo simulations. In vivo
investigations revealed that tailored administration reduces
toxicity while increasing antiviral activity.
[]
Creating carrier–drug-
release profiles
For a combination therapy with various drug release characteristics,
a dual-compartment liposomal nanocarrier was developed. The
design was guided by quantum mechanics models, while in vitro
dissolution studies supported the optimized release patterns.
[]
These case studies demonstrate the effectiveness of simulation-based methodologies
in nanocarrier selection, which leads to enhanced drug delivery profiles. They also
emphasize the significance of combining simulations and experimental data to ad-
dress issues, as well as the iterative characteristic of this research approach.
12.6.1 Challenges
While simulation-based approaches have numerous advantages, they are not without
drawbacks. These are the few challenges faced by simulation systems:
12 Application of simulation system for selection of nanocarrier 291
https://t.me/med1917
12.6.2 Difficulties in anticipating biological response
One difficulty that researchers come across is p recisely anticipating biological reac-
tions to nanocarriers. While simulations can provide molecular insights into carrier–
drug interactions, interpreting these interactions within real-world biological effects
can be difficult. To solve this issue, researchers have discovered the value of combin-
ing simulation results with a experimental data to improve and validate predic-
tions [95].
12.6.3 Variability in the real world
The real-world unpredictability of physiological variables and responses from pa-
tients can provide difficulties in some cases. This variability may not be properly rep-
resented by simulation methods. A margin of safety should be considered when
selecting nanocarriers, and clinical trials should be done to assure efficacy over a
wide variety of patient circumstances.
12.6.4 Iterative characteristics of simulation-based approaches
Researchers frequently need to examine and improve their simulations in response to
new experimental evidence and expanding knowledge. To continuously optimize
DDSs, successful nanocarrier selection requires an ongoing process of simulations,
validation, and adjustment [96].
12.7 Future perspectives and emerging trends
12.7.1 Advancements in simulation systems: shaping the future
of nanocarrier selection
Over time, simulation systems have seen tremendous evolution, going beyond their con-
ventional use in teaching and entertainment. Simulation systems are becoming essen-
tial instruments in scientific research and development, especially in areas of drug
delivery and nanotechnology. With the help of these virtual environments, scientists
may model and simulate intricate situations and gain insights that are frequently diffi-
cult to gain through traditional experimentation alone [97]. In light of this, investigating
new technologies and approaches in simulation systems is essential to comprehending
how they might affect nanocarrier selection, a critical component of drug delivery
systems.
292 Abhishek Singh et al.
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана